Investment Q&A

Q: Is there any hope for this one? I am down way big time on it, to the point that if it fell off the board it wouldn't make much of a difference. I will hang on to it if there is any hope, if not its time to clean up. Thanks wayne

Q: Hi Team, Sorry about just copying this info, but RBC is doing a better job than I could:
12:23 PM EDT, 05/03/2017 (MT Newswires) -- RBC Capital is initiating coverage on TSO3 with an Outperform, Speculative Risk rating and C$4.25 target. TSO3 has recently commercialized a proprietary and highly differentiated device for the sterilization of medical devices, particularly endoscopes, in healthcare settings, the brokerage reports, adding that the company is therefore uniquely positioned with its marketing partner, Getinge (a world leader in infection control sales). "We expect greater than ~40% returns over the next 12-months."
Price: 3.17, Change: +0.08, Percent Change: +2.6
Would you agree or disagree with RBC on TSO3?
Thanks, Chris

Q: Further to my question on May 4,Mnw tanked the last 2 days.Is there any reason(s)?It may have dropped after the conference call on May 4 morning.If possible do not deduct a credit.Thanks for your usual great services & views

Q: Just a follow up on the question today about healthy menu companies, I might suggest Ten Peaks as well. Decaf coffee sales are on the rise and the Swiss Water Process ( ie Ten Peaks) is regarded as the premier method. Their 1st Q earnings come out next week so we will have a better idea of business at that time.

Q: Would you agree the latest acquisition of a business to business provider could reduce costs of their funeral home operations, thus increasing margins long term?
If so, can it be seen as an excellent strategic fit to the growth platform, and thus support current share price momentum?

Q: The shares of PYR have moved up today and a company with the symbol HPQ announce it has ordered a second phase of Process Characterization Testing from PyroGenesis; alas, the HPQ in question is not Hewlett-Packard but a much smaller company "HPQ Silicon Resources" which is listed in Frankfurt and on the TSX-Venture exchange.

What can you tell us about this TSX.V-listed HPQ and is its announced relationship with PYR meaningful for the continuing progress of Pyrogenesis Canada?

Thanks to the 5i team for their informative insights.

Q: CHH has issued a press release of their signing a New 5-year Credit Facilities for Completion of Debt Refinancing Plan. The reduction in borrowing costs from $26.4M in 2015 to a pro-forma of $4.5M along with a reduction in their weighted average interest rate from 6.7% to 5.25% is impressive. Would you please provide your assessment of this company and also comment if it time to buy this stock? Thanks Gordon

Q: What is your current
View of BUS at the
2.60$ level over the
Next 12 months ?
Thanks. Barry.

Q: Comments please on their latest quarterly results.

Thanks for your input.
John

Q: What do you think of their earnings.The chart looks interesting.
ANDREW

Q: Would you consider Acuityads to be a worthy addition to a growth portfolio? Thanks again

Q: Good evening,

Can I please get your take on the DRT numbers? It looks underwhelming at first glance. Management seems to be spinning it as positive as Q1 is typically soft. Interested in your thoughts.

Q: the recent results would indicate that spot coffee is showing signs of finally getting off the ground.
Do you agree?

Q: I have been watching this micro cap (Eurocontrol Technics - EUO)for awhile now. After the sale of one of their technologies early last year the company is now trading at approximately cash / cash equivalents on the balance sheet and it boasts some interesting imagery & composition technology in the semiconductor measurement space which is just entering the commercial stage. The technology seems somewhat aligned with Photon Controls business which has done wonders. Would this be an interesting business combination? What do you think of EUO as a micro cap speculation for high risk capital?

Thanks

Q: Would you rank the following companies as to your expectations for total return on a 3 year hold.GPS,ITC,AT,PIH,MPVD,IFR. Thanks.

Q: Was D-Box dropped from the growth portfolio as a result of a specific event or news release? I.e., why not wait for the next earnings release to make a decision?

Thanks!
Tom

Q: I've been interested in NXO lately due to the market activity so I did a bit of research on the technology itself. The theory of flat lenses and the proof of concept that it works was discovered by Federico Capasso and his team at Harvard University. When their research paper was first published, Federico Capasso was contacted by one of the world's largest smartphone manufactures (which means they are now working on it). Since then many of the research team members have been picked off by various universities and companies world wide to develop it's potential further.
The point is (NXO) Nexoptic did not invent the technology of their prototype lens system.
So investors beware that NXO really has nothing proprietary, nor do they have the size and scale of potential competitors. The idea that an iPhone will someday have Nexoptic lenses is probably a bit of a stretch. The best outcome I see is that their telescope patent (if approved) is sold to a larger manufacturer, which is not going to make the average investor any money over the next 5 years.
I hope I'm wrong and wish them luck!

Shane

Q: This little upstart fintech released earnings May 1st. Showed huge revenue growth and cashflow for Q1. Risky venture stock but growth potential looks good. Appreciate your thoughts on this one.

Q: What do you think of Royalty North? They just signed a few deals. Still no dividend, but do you think it is coming? Are they issuing too many shares and warrants to make this worthwhile holding?

Q: Interested in your thoughts on last week's acquisition by Hamilton Thorne of Gynemed GmbH & Co. What impact do you see on future earnings. The market appears to like the deal.